Company: OSRH
Filing Date: 2025-10-16
Form Type: 8-K
Source: 0001213900-25-099393
Chunk: 0

Company: OSR Holdings, Inc.
Filing Date: 2025-10-16
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On October 13, 2025, OSR Holdings Co., Ltd. (“ OSRK”), a
wholly owned subsidiary of OSR Holdings Inc. (NASDAQ: OSRH, the “ Company”), entered into a Share Exchange Agreement (the “ Agreement”)
with Woori IO Co., Ltd. (“ WORIO”). Under the Agreement, OSRK will acquire all issued and outstanding shares of WORIO through
a comprehensive share exchange under the Korean Commercial Act, and WORIO will become a wholly owned subsidiary of OSRK and indirectly
of the Company.

WORIO is a South Korea-based medical-device company
developing non-invasive biosensing technology for glucose monitoring and related health parameters. Its proprietary near-infrared spectroscopy
(NIRS) platform aims to enable needle-free continuous glucose monitoring for diabetes patients. Of particular note, WORIO has been providing
technical development services to Samsung Electronics (“ Samsung”) under a Non-invasive Blood Glucose Monitor PoC Development
Services Agreement(“ Service Agreement”) pursuant to which Samsung provided WORIO with a certain amount of non-dilutive funding.
The details of such funding will not be disclosed in order to protect Samsung’s business confidentiality. This Service Agreement
serves as the basis for WORIO to conduct the trials to test the Proof of Concept of WORIO’s NIRS technologies in monitoring and
collecting data on blood glucose levels of the patients who participated in the trials. These programs, conducted under the Service Agreement,
provide collaborative support for product validation and pilot testing of WORIO’s non-invasive glucose monitoring devices.

Each WORIO share will be exchanged for 0.948832 OSRK
shares, and OSRK will issue 84,338 new shares in total to the existing WORIO shareholders in exchange for their 88,891 WORIO shares. The
aggregate transaction value is approximately KRW 15 billion (USD 10.6 million).

The closing of the transaction is subject to customary conditions including
shareholder approval by WORIO (target meeting date December 19, 2025) and regulatory clearances. The effective date of the share exchange
is expected to be January 12, 2026.

Under Annex 2 of the Agreement, if within three years after closing
the Company’s common stock reaches USD 10.00 per share on NASDAQ, the OSRK shares received by former WORIO